{"id":"https://openalex.org/W2039714619","doi":"https://doi.org/10.1200/edbook_am.2013.33.301","title":"The Role of JAK1/2 Inhibitors in the Treatment of Chronic Myeloproliferative Neoplasms","display_name":"The Role of JAK1/2 Inhibitors in the Treatment of Chronic Myeloproliferative Neoplasms","publication_year":2013,"publication_date":"2013-01-01","ids":{"openalex":"https://openalex.org/W2039714619","doi":"https://doi.org/10.1200/edbook_am.2013.33.301","mag":"2039714619","pmid":"https://pubmed.ncbi.nlm.nih.gov/23714529"},"language":"en","primary_location":{"id":"doi:10.1200/edbook_am.2013.33.301","doi":"https://doi.org/10.1200/edbook_am.2013.33.301","is_oa":false,"landing_page_url":"https://doi.org/10.1200/edbook_am.2013.33.301","pdf_url":null,"source":{"id":"https://openalex.org/S4210215109","display_name":"American Society of Clinical Oncology Educational Book","issn_l":"1548-8748","issn":["1548-8748","1548-8756","1930-7020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","ki-jl-1","medline","poland-40","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320068","host_organization_name":"American Society of Clinical Oncology","host_organization_lineage":["https://openalex.org/P4310320068"],"host_organization_lineage_names":["American Society of Clinical Oncology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Society of Clinical Oncology Educational Book","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109272813","display_name":"Clodagh Keohane","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1298207432","display_name":"Guy's Hospital","ror":"https://ror.org/04r33pf22","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1298207432","https://openalex.org/I200166805","https://openalex.org/I4210111135"]},{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]},{"id":"https://openalex.org/I200166805","display_name":"Guy's and St Thomas' NHS Foundation Trust","ror":"https://ror.org/00j161312","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I200166805"]},{"id":"https://openalex.org/I4210127938","display_name":"Mayo Clinic Hospital","ror":"https://ror.org/03660jn93","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210125099","https://openalex.org/I4210127938"]},{"id":"https://openalex.org/I4390039332","display_name":"Mayo Clinic Comprehensive Cancer Center (Arizona)","ror":"https://ror.org/003xpy695","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210125099","https://openalex.org/I4390039332"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"Clodagh Keohane","raw_affiliation_strings":["From the Department of Haematology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom; Division of Hematology and Medical Oncology, Mayo Clinic Cancer Center, Phoenix, AZ","Division of Hematology and Medical Oncology, Mayo Clinic Cancer Center, Phoenix, AZ","From the Department of Haematology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Department of Haematology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom; Division of Hematology and Medical Oncology, Mayo Clinic Cancer Center, Phoenix, AZ","institution_ids":["https://openalex.org/I1298207432","https://openalex.org/I1330342723","https://openalex.org/I200166805","https://openalex.org/I4390039332"]},{"raw_affiliation_string":"Division of Hematology and Medical Oncology, Mayo Clinic Cancer Center, Phoenix, AZ","institution_ids":["https://openalex.org/I4210127938","https://openalex.org/I4390039332"]},{"raw_affiliation_string":"From the Department of Haematology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom","institution_ids":["https://openalex.org/I200166805"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039057642","display_name":"Ruben A. Mesa","orcid":"https://orcid.org/0000-0001-5880-7972","observed_orcids":["https://orcid.org/0000-0001-5880-7972"]},"institutions":[{"id":"https://openalex.org/I1298207432","display_name":"Guy's Hospital","ror":"https://ror.org/04r33pf22","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1298207432","https://openalex.org/I200166805","https://openalex.org/I4210111135"]},{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]},{"id":"https://openalex.org/I200166805","display_name":"Guy's and St Thomas' NHS Foundation Trust","ror":"https://ror.org/00j161312","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I200166805"]},{"id":"https://openalex.org/I4210127938","display_name":"Mayo Clinic Hospital","ror":"https://ror.org/03660jn93","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210125099","https://openalex.org/I4210127938"]},{"id":"https://openalex.org/I4390039332","display_name":"Mayo Clinic Comprehensive Cancer Center (Arizona)","ror":"https://ror.org/003xpy695","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210125099","https://openalex.org/I4390039332"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"Ruben Mesa","raw_affiliation_strings":["From the Department of Haematology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom; Division of Hematology and Medical Oncology, Mayo Clinic Cancer Center, Phoenix, AZ","Division of Hematology and Medical Oncology, Mayo Clinic Cancer Center, Phoenix, AZ","From the Department of Haematology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Department of Haematology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom; Division of Hematology and Medical Oncology, Mayo Clinic Cancer Center, Phoenix, AZ","institution_ids":["https://openalex.org/I1298207432","https://openalex.org/I1330342723","https://openalex.org/I200166805","https://openalex.org/I4390039332"]},{"raw_affiliation_string":"Division of Hematology and Medical Oncology, Mayo Clinic Cancer Center, Phoenix, AZ","institution_ids":["https://openalex.org/I4210127938","https://openalex.org/I4390039332"]},{"raw_affiliation_string":"From the Department of Haematology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom","institution_ids":["https://openalex.org/I200166805"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5046827092","display_name":"Claire N. Harrison","orcid":"https://orcid.org/0000-0002-3212-920X","observed_orcids":["https://orcid.org/0000-0002-3212-920X"]},"institutions":[{"id":"https://openalex.org/I1298207432","display_name":"Guy's Hospital","ror":"https://ror.org/04r33pf22","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1298207432","https://openalex.org/I200166805","https://openalex.org/I4210111135"]},{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]},{"id":"https://openalex.org/I200166805","display_name":"Guy's and St Thomas' NHS Foundation Trust","ror":"https://ror.org/00j161312","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I200166805"]},{"id":"https://openalex.org/I4210127938","display_name":"Mayo Clinic Hospital","ror":"https://ror.org/03660jn93","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210125099","https://openalex.org/I4210127938"]},{"id":"https://openalex.org/I4390039332","display_name":"Mayo Clinic Comprehensive Cancer Center (Arizona)","ror":"https://ror.org/003xpy695","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210125099","https://openalex.org/I4390039332"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"Claire Harrison","raw_affiliation_strings":["From the Department of Haematology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom; Division of Hematology and Medical Oncology, Mayo Clinic Cancer Center, Phoenix, AZ","Division of Hematology and Medical Oncology, Mayo Clinic Cancer Center, Phoenix, AZ","From the Department of Haematology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Department of Haematology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom; Division of Hematology and Medical Oncology, Mayo Clinic Cancer Center, Phoenix, AZ","institution_ids":["https://openalex.org/I1298207432","https://openalex.org/I1330342723","https://openalex.org/I200166805","https://openalex.org/I4390039332"]},{"raw_affiliation_string":"Division of Hematology and Medical Oncology, Mayo Clinic Cancer Center, Phoenix, AZ","institution_ids":["https://openalex.org/I4210127938","https://openalex.org/I4390039332"]},{"raw_affiliation_string":"From the Department of Haematology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom","institution_ids":["https://openalex.org/I200166805"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.594,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":{"value":0.66211604,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":96},"biblio":{"volume":"33","issue":"33","first_page":"301","last_page":"305"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/jak1-2-inhibitor","display_name":"JAK1/2 inhibitor","score":0.9860000014305115},{"id":"https://openalex.org/keywords/myeloproliferative-neoplasms","display_name":"myeloproliferative neoplasms","score":0.9520000219345093},{"id":"https://openalex.org/keywords/myelofibrosis","display_name":"myelofibrosis","score":0.9589999914169312},{"id":"https://openalex.org/keywords/jak2-v617f-mutation","display_name":"JAK2 V617F mutation","score":0.9380000233650208},{"id":"https://openalex.org/keywords/ruxolitinib","display_name":"ruxolitinib","score":0.9990000128746033},{"id":"https://openalex.org/keywords/jak-inhibitors","display_name":"JAK inhibitors","score":0.5870000123977661},{"id":"https://openalex.org/keywords/splenomegaly","display_name":"splenomegaly","score":0.8450000286102295},{"id":"https://openalex.org/keywords/survival","display_name":"survival","score":0.48399999737739563},{"id":"https://openalex.org/keywords/mechanism-of-action","display_name":"mechanism of action","score":0.6570000052452087},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.6200000047683716}],"concepts":[{"id":"https://openalex.org/C2776112149","wikidata":"https://www.wikidata.org/wiki/Q7383611","display_name":"Ruxolitinib","level":4,"score":0.9325757026672363},{"id":"https://openalex.org/C2780076729","wikidata":"https://www.wikidata.org/wiki/Q1752571","display_name":"Myelofibrosis","level":3,"score":0.9227675199508667},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7337636947631836},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5477634072303772},{"id":"https://openalex.org/C2910274570","wikidata":"https://www.wikidata.org/wiki/Q1898104","display_name":"Myeloproliferative Disorders","level":2,"score":0.522800087928772},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.5153055191040039},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4724465012550354},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4594399034976959},{"id":"https://openalex.org/C2781057849","wikidata":"https://www.wikidata.org/wiki/Q1368780","display_name":"Essential thrombocythemia","level":3,"score":0.4526618719100952},{"id":"https://openalex.org/C2778837598","wikidata":"https://www.wikidata.org/wiki/Q948318","display_name":"Polycythemia vera","level":2,"score":0.3589414060115814},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.1277565062046051}],"mesh":[{"descriptor_ui":"D000096926","descriptor_name":"Benzenesulfonamides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001549","descriptor_name":"Benzamides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001952","descriptor_name":"Bridged-Ring Compounds","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009196","descriptor_name":"Myeloproliferative Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009196","descriptor_name":"Myeloproliferative Disorders","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D009196","descriptor_name":"Myeloproliferative Disorders","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D009570","descriptor_name":"Nitriles","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011759","descriptor_name":"Pyrrolidines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D053613","descriptor_name":"Janus Kinase 1","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D053614","descriptor_name":"Janus Kinase 2","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D053614","descriptor_name":"Janus Kinase 2","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D058990","descriptor_name":"Molecular Targeted Therapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1200/edbook_am.2013.33.301","doi":"https://doi.org/10.1200/edbook_am.2013.33.301","is_oa":false,"landing_page_url":"https://doi.org/10.1200/edbook_am.2013.33.301","pdf_url":null,"source":{"id":"https://openalex.org/S4210215109","display_name":"American Society of Clinical Oncology Educational Book","issn_l":"1548-8748","issn":["1548-8748","1548-8756","1930-7020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","ki-jl-1","medline","poland-40","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320068","host_organization_name":"American Society of Clinical Oncology","host_organization_lineage":["https://openalex.org/P4310320068"],"host_organization_lineage_names":["American Society of Clinical Oncology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Society of Clinical Oncology Educational Book","raw_type":"journal-article"},{"id":"doi:10.14694/edbook_am.2013.33.301","doi":"https://doi.org/10.14694/edbook_am.2013.33.301","is_oa":false,"landing_page_url":"https://doi.org/10.14694/edbook_am.2013.33.301","pdf_url":null,"source":{"id":"https://openalex.org/S4210215109","display_name":"American Society of Clinical Oncology Educational Book","issn_l":"1548-8748","issn":["1548-8748","1548-8756","1930-7020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","ki-jl-1","medline","poland-40","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320068","host_organization_name":"American Society of Clinical Oncology","host_organization_lineage":["https://openalex.org/P4310320068"],"host_organization_lineage_names":["American Society of Clinical Oncology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Society of Clinical Oncology Educational Book","raw_type":"journal-article"},{"id":"pmid:23714529","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23714529","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":16,"referenced_works":["https://openalex.org/W1545484310","https://openalex.org/W1970369998","https://openalex.org/W1971487953","https://openalex.org/W1993072636","https://openalex.org/W1993934088","https://openalex.org/W2010075352","https://openalex.org/W2019970875","https://openalex.org/W2040664937","https://openalex.org/W2071832964","https://openalex.org/W2106875723","https://openalex.org/W2115351357","https://openalex.org/W2121743767","https://openalex.org/W2123633897","https://openalex.org/W2151027920","https://openalex.org/W2157066112","https://openalex.org/W2330125896"],"related_works":["https://openalex.org/W2464231274","https://openalex.org/W2164845217","https://openalex.org/W2122534355","https://openalex.org/W1986595955","https://openalex.org/W2118323591","https://openalex.org/W2084831908","https://openalex.org/W7099446140","https://openalex.org/W2079327299","https://openalex.org/W2615765466","https://openalex.org/W1994797967"],"abstract_inverted_index":{"In":[0,30],"2005,":[1],"the":[2,5,9,27,32,56,86,143,152,155,197,200,214],"description":[3],"of":[4,52,79,145,161,199,217],"JAK2V617F":[6,57],"mutation":[7],"for":[8,23,168],"first":[10,41],"time":[11],"provided":[12],"a":[13,123,204,210],"molecular":[14,178],"key":[15],"to":[16,113,213],"enable":[17],"more":[18],"rapid":[19],"diagnosis":[20],"and":[21,74,119,134,158,180,207],"target":[22],"novel":[24],"therapeutics":[25],"in":[26,43,67,75,103,108],"myeloproliferative":[28],"neoplasms.":[29],"2007,":[31],"first-in-class":[33],"agent":[34,63],"INC18424,":[35],"ruxolitinib,":[36],"JAKafi,":[37],"or":[38,48,116,194],"JAKAVI":[39],"was":[40,83],"tested":[42],"patients":[44],"with":[45,61,91,126],"intermediate-risk":[46],"2":[47],"high-risk":[49],"myelofibrosis":[50],"regardless":[51],"whether":[53,185],"they":[54],"possessed":[55],"mutation.":[58],"Patients":[59],"treated":[60],"this":[62,127],"had":[64],"major":[65],"reduction":[66],"splenomegaly":[68],"as":[69,71],"well":[70],"impressive":[72],"reduction,":[73],"some":[76],"cases":[77],"resolution,":[78],"symptoms.":[80],"This":[81,129],"study":[82],"followed":[84],"by":[85],"two":[87],"Controlled":[88],"Myelofibrosis":[89],"Study":[90],"Oral":[92],"JAK":[93,138,201],"Inhibitor":[94],"Therapy":[95],"(COMFORT)":[96],"trials":[97,102],"(the":[98],"first-ever":[99],"phase":[100],"III":[101],"myelofibrosis),":[104],"which":[105],"confirmed":[106],"results":[107,121,133],"these":[109,132,146,173,218],"aspects":[110],"were":[111],"superior":[112],"either":[114],"placebo":[115],"standard":[117],"care,":[118],"updated":[120],"show":[122],"survival":[124],"advantage":[125],"therapy.":[128],"paper":[130],"discusses":[131],"data":[135],"from":[136],"other":[137],"inhibitors":[139],"while":[140],"speculating":[141],"on":[142,151],"future":[144],"therapies.":[147],"It":[148],"also":[149],"reflects":[150],"fact":[153],"that":[154],"true":[156],"targets":[157],"agents'":[159],"mode":[160],"action":[162],"are":[163],"uncertain.":[164],"Unlike":[165],"targeted":[166],"therapy":[167],"chronic":[169],"myeloid":[170],"leukemia":[171],"(CML),":[172],"agents":[174],"do":[175],"not":[176,183],"deliver":[177],"remission,":[179],"it":[181],"is":[182,189,203],"clear":[184],"their":[186],"predominant":[187],"benefit":[188],"mediated":[190],"via":[191],"JAK2,":[192],"JAK1,":[193],"both.":[195],"Nonetheless,":[196],"advent":[198],"inhibitor":[202],"welcome":[205],"advance":[206],"has":[208],"made":[209],"dramatic":[211],"improvement":[212],"therapeutic":[215],"landscape":[216],"conditions.":[219]},"counts_by_year":[{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}